Point of Care Drugs of Abuse
Midlands Partnership Foundation TrustcontractContracts Finder ↗Ref 20201126084903-67601SME suitablecomplete
Estimated value
£1
Awarded value
£160k
Awarded 26 Nov 2020
Suppliers
1
Lots
1
1 awarded
Published
26 Nov 2020
Deadline 21 Sept 2020
Description
To source a provider to support delivery of Substance Misuse services across the MPFT footprint. The procurement is to deliver a standardised range of point of care testing products and associated services relating to Drugs of Abuse.
Scope
- Reference
- 20201126084903-67601
- Total value
- £1 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Dec 2020 to 30 Nov 2023
- CPV classifications
- 33696200 38911000 85111800
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 21 Sept 2020, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£160k
Award date
26 Nov 2020
Contract start
01 Dec 2020
Contract end
30 Nov 2023
Awarded to
Awarded suppliers· 1 supplier
Awarded 26 Nov 2020 · Contract period 01 Dec 2020 — 30 Nov 2023
Award value
£160k
Other contracts from Midlands Partnership Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Matrix Diagnostics Limited· 7
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service | contract | — | 29 Sept 2023 |
| DRUG OF ABUSE AND POINT OF CARE TESTING (SBS10241) | contract | — | 11 Aug 2023 |
| Substance Misuse Point of Care Testing: Devices and Associated Laboratory Tests | contract | — | 21 Dec 2021 |
| Substance Misuse Point of Care Testing Devices and Associated Laboratory Testing | call off | £266k | 21 Dec 2021 |
| DNA, Drugs and Alcohol Testing Services Framework | contract | — | 13 May 2021 |
| DNA, Drugs and Alcohol Testing Services Framework | call off | £634k | 13 May 2021 |
| Point of Care Testing: Drugs of Abuse | contract | £46.7m | 05 Feb 2018 |